244 related articles for article (PubMed ID: 24563618)
1. HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Sconocchia G; Eppenberger-Castori S; Zlobec I; Karamitopoulou E; Arriga R; Coppola A; Caratelli S; Spagnoli GC; Lauro D; Lugli A; Han J; Iezzi G; Ferrone C; Ferlosio A; Tornillo L; Droeser R; Rossi P; Attanasio A; Ferrone S; Terracciano L
Neoplasia; 2014 Jan; 16(1):31-42. PubMed ID: 24563618
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
3. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
4. IL-4 and granulocyte-macrophage colony-stimulating factor selectively increase HLA-DR and HLA-DP antigens but not HLA-DQ antigens on human monocytes.
Gerrard TL; Dyer DR; Mostowski HS
J Immunol; 1990 Jun; 144(12):4670-4. PubMed ID: 2112573
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of MHC class II genes in lung tumour cell lines.
Redondo M; Ruiz-Cabello F; Concha A; Hortas ML; Serrano A; Morell M; Garrido F
Eur J Immunogenet; 1998 Dec; 25(6):385-91. PubMed ID: 9949943
[TBL] [Abstract][Full Text] [Related]
7. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
8. Impaired antigen-presenting capability of monocytes correlated with their decreased expression of HLA-II antigens in patients with myeloid leukemia.
Gong FL; Feng XW; Grosse-Wilde H
J Tongji Med Univ; 1993; 13(2):65-70. PubMed ID: 8230358
[TBL] [Abstract][Full Text] [Related]
9. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
Muczynski KA; Cotner T; Anderson SK
Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
[TBL] [Abstract][Full Text] [Related]
10. Altered expression levels of HLA class Ⅱ and costimulatory molecules on circulating monocytes from patients with cervical intraepithelial neoplasia and squamous cervical cancer.
Feng T; Zhou JH; Liu J; Ye F; Lu W; Xie X
Mol Med Rep; 2012 Dec; 6(6):1301-4. PubMed ID: 22965188
[TBL] [Abstract][Full Text] [Related]
11. Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine.
Horie Y; Chiba M; Iizuka M; Masamune O
Gastroenterol Jpn; 1990 Oct; 25(5):575-84. PubMed ID: 2227249
[TBL] [Abstract][Full Text] [Related]
12. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
13. Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2.
Horie Y; Chiba M; Suzuki T; Kudo T; Kamata A; Iizuka M; Masamune O
J Gastroenterol; 1998 Feb; 33(1):39-47. PubMed ID: 9497220
[TBL] [Abstract][Full Text] [Related]
14. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes.
Sadeghi R; Hawrylowicz CM; Chernajovsky Y; Feldmann M
Cytokine; 1992 Jul; 4(4):287-97. PubMed ID: 1515553
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
16. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.
Matsushita K; Takenouchi T; Shimada H; Tomonaga T; Hayashi H; Shioya A; Komatsu A; Matsubara H; Ochiai T
Cancer Sci; 2006 Jan; 97(1):57-63. PubMed ID: 16367922
[TBL] [Abstract][Full Text] [Related]
17. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
18. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma.
Iwata M; Kiritoshi A; Roat MI; Yagihashi A; Thoft RA
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2714-21. PubMed ID: 1639617
[TBL] [Abstract][Full Text] [Related]
20. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Dengjel J; Nastke MD; Gouttefangeas C; Gitsioudis G; Schoor O; Altenberend F; Müller M; Krämer B; Missiou A; Sauter M; Hennenlotter J; Wernet D; Stenzl A; Rammensee HG; Klingel K; Stevanović S
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4163-70. PubMed ID: 16857787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
